Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial

The FDA has placed a clinical hold on Ocugen Inc (NASDAQ:OCGN) Phase 2/3 immuno-bridging and broadening study for COVAXIN (BBV152) OCU-002. 

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.